azelastine and simvastatin

azelastine has been researched along with simvastatin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Chen, W; Enomoto, N; Kasai, H; Maekawa, S; Matsuura, Y; Moriishi, K; Okamoto, T; Okuyama-Dobashi, K; Ryo, A; Suzuki, T; Tanaka, T; Wakita, T; Watashi, K; Yamashita, A; Yasumoto, J	1

Other Studies

2 other study(ies) available for azelastine and simvastatin

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide. Scientific reports, 2015, Nov-23, Volume: 5 Topics: Antiviral Agents; Bufanolides; Cell Adhesion; Digitoxin; Digoxin; Gene Expression; Hep G2 Cells; Hepatitis B virus; High-Throughput Screening Assays; Humans; Organic Anion Transporters, Sodium-Dependent; Phthalazines; Proscillaridin; Receptors, Virus; Simvastatin; Strophanthins; Symporters; Transgenes; Viral Envelope Proteins; Virus Internalization	2015

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide.

Scientific reports, 2015, Nov-23, Volume: 5

Topics: Antiviral Agents; Bufanolides; Cell Adhesion; Digitoxin; Digoxin; Gene Expression; Hep G2 Cells; Hepatitis B virus; High-Throughput Screening Assays; Humans; Organic Anion Transporters, Sodium-Dependent; Phthalazines; Proscillaridin; Receptors, Virus; Simvastatin; Strophanthins; Symporters; Transgenes; Viral Envelope Proteins; Virus Internalization

2015